StockData
Xenetic Biosciences, Inc. logo

Xenetic Biosciences, Inc. (XBIO) stock

XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3064% below fair value
$1.53−0.08 (-4.97%)

Close on Nov 18, 2026Market cap $3.59MP/E –Yield –

Xenetic Biosciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Xenetic Biosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$2.31M. For fiscal 2025 it was -$2.29M. The highest annual figure on record is $1.49M in fiscal 2017.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.29M–
FY2024Dec 31, 2024-$2.82M–
FY2023Dec 31, 2023-$4.11M–
FY2022Dec 31, 2022-$4.65M–
FY2021Dec 31, 2021-$4.74M–
FY2020Dec 31, 2020-$4.27M–
FY2019Dec 31, 2019-$6.40M–
FY2018Dec 31, 2018-$6.46M-532.6%
FY2017Dec 31, 2017$1.49M–
FY2016Dec 31, 2016-$8.79M–
FY2015Dec 31, 2015-$5.30M–
FY2014Dec 31, 2014-$12.68M–
FY2013Dec 31, 2013-$6.05M–
FY2012Dec 31, 2012-$6.26M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$875.49K–
Q1 FY2026Mar 31, 2026-$536.38K–
Q4 FY2025Dec 31, 2025-$242.68K–
Q3 FY2025Sep 30, 2025-$658.25K–
Q2 FY2025Jun 30, 2025-$383.83K–
Q1 FY2025Mar 31, 2025-$1.00M–
Q4 FY2024Dec 31, 2024-$673.99K–
Q3 FY2024Sep 30, 2024-$459.04K–
Q2 FY2024Jun 30, 2024-$525.10K–
Q1 FY2024Mar 31, 2024-$1.16M–
Q4 FY2023Dec 31, 2023-$793.03K–
Q3 FY2023Sep 30, 2023-$949.63K–
Q2 FY2023Jun 30, 2023-$1.27M–
Q1 FY2023Mar 31, 2023-$1.10M–
Q2 FY2022Jun 30, 2022-$728.90K–
Q1 FY2022Mar 31, 2022-$2.09M–
Q4 FY2021Dec 31, 2021-$1.46M–
Q3 FY2021Sep 30, 2021-$1.03M–
Q2 FY2021Jun 30, 2021-$726.81K–
Q1 FY2021Mar 31, 2021-$1.52M–
Q4 FY2020Dec 31, 2020-$953.66K–
Q3 FY2020Sep 30, 2020-$1.01M–
Q2 FY2020Jun 30, 2020-$1.30M–
Q1 FY2020Mar 31, 2020-$1.00M–
Q4 FY2019Dec 31, 2019-$1.68M–
Q3 FY2019Sep 30, 2019-$2.42M–
Q2 FY2019Jun 30, 2019-$1.05M–
Q1 FY2019Mar 31, 2019-$1.25M–
Q4 FY2018Dec 31, 2018-$1.04M-121.5%
Q3 FY2018Sep 30, 2018-$1.67M–
Q2 FY2018Jun 30, 2018-$2.09M–
Q1 FY2018Mar 31, 2018-$1.67M-693.6%
Q4 FY2017Dec 31, 2017$4.84M–
Q3 FY2017Sep 30, 2017-$1.64M–
Q2 FY2017Jun 30, 2017-$1.99M–
Q1 FY2017Mar 31, 2017$280.81K–
Q4 FY2016Dec 31, 2016-$4.62M–
Q3 FY2016Sep 30, 2016-$1.03M–
Q2 FY2016Jun 30, 2016-$1.36M–

More Xenetic Biosciences figures

See a number that looks wrong?